Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 6:43 pm Purchase | 2021-12-31 | 13G | Scopus BioPharma Inc. SCPS | Armistice Capital, LLC | 2,100,000 9.960% | 2,100,000 (New Position) | Filing History |
| 2021-11-26 5:04 pm Purchase | 2021-11-23 | 13D | Scopus BioPharma Inc. SCPS | HCFP/Capital Partners 18B-1 LLC | 1,587,092 7.500% | 83,758 (+5.57%) | Filing History |
| 2021-11-26 5:00 pm Purchase | 2021-11-23 | 13D | Scopus BioPharma Inc. SCPS | SCPS/Strategic Capital Partners LLC | 1,305,108 5.900% | 5,850 (+0.45%) | Filing History |
| 2021-11-26 5:00 pm Sale | 2021-11-23 | 13D | Scopus BioPharma Inc. SCPS | HCFP/Capital Partners 18B-2 LLC | 237,092 1.100% | -2,994,150 (-92.66%) | Filing History |
| 2021-08-12 07:13 am Purchase | 2021-08-02 | 13D | Scopus BioPharma Inc. SCPS | HCFP/Capital Partners 18B-2 LLC | 3,231,242 15.300% | 3,231,242 (New Position) | Filing History |
| 2021-08-12 07:03 am Purchase | 2021-08-02 | 13D | Scopus BioPharma Inc. SCPS | SCPS/Strategic Capital Partners LLC | 1,299,258 6.800% | 1,299,258 (New Position) | Filing History |
| 2021-07-12 8:20 pm Purchase | 2021-06-25 | 13G | Scopus BioPharma Inc. SCPS | Kortylewski Marcin | 911,079 5.000% | 911,079 (New Position) | Filing History |
| 2021-05-11 6:58 pm Purchase | 2021-05-10 | 13D | Scopus BioPharma Inc. SCPS | Laster Morris C | 6,006,000 40.100% | 1,080,000 (+21.92%) | Filing History |
| 2021-04-06 6:43 pm Purchase | 2021-04-01 | 13D | Scopus BioPharma Inc. SCPS | Laster Morris C | 4,926,000 32.900% | 4,926,000 (New Position) | Filing History |
| 2021-02-12 9:51 pm Purchase | 2020-12-31 | 13G | Scopus BioPharma Inc. SCPS | HCFP/Capital Partners 18B-1 LLC | 1,503,334 10.300% | 1,503,334 (New Position) | Filing History |